Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers

Oncotarget
Hamid H GariJames R Lambert

Abstract

Triple-negative breast cancers (TNBC) are among the most aggressive and heterogeneous cancers with a high propensity to invade, metastasize and relapse. Here, we demonstrate that the anticancer compound, AMPI-109, is selectively efficacious in inhibiting proliferation and inducing apoptosis of multiple TNBC subtype cell lines as assessed by activation of pro-apoptotic caspases-3 and 7, PARP cleavage and nucleosomal DNA fragmentation. AMPI-109 had little to no effect on growth in the majority of non-TNBC cell lines examined. We therefore utilized AMPI-109 in a genome-wide shRNA screen in the TNBC cell line, BT-20, to investigate the utility of AMPI-109 as a tool in helping to identify molecular alterations unique to TNBC. Our screen identified the oncogenic phosphatase, PRL-3, as a potentially important driver of TNBC growth, migration and invasion. Through stable lentiviral knock downs and transfection with catalytically impaired PRL-3 in TNBC cells, loss of PRL-3 expression, or functionality, led to substantial growth inhibition. Moreover, AMPI-109 treatment, downregulation of PRL-3 expression or impairment of PRL-3 activity reduced TNBC cell migration and invasion. Histological evaluation of human breast cancers revealed PRL-...Continue Reading

References

Jan 26, 1996·The Journal of Biological Chemistry·R RayM F Holick
Dec 20, 1996·Cancer Letters·C A CatesD N Crowell
May 18, 2001·Biochemical and Biophysical Research Communications·W F MatterC J Vlahos
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Oct 5, 2001·Molecular and Cellular Biology·J N AndersenN P Møller
Oct 13, 2001·Science·S SahaB Vogelstein
Oct 21, 2003·International Journal of Cancer. Journal International Du Cancer·Kelli M BullardJames B McCarthy
Nov 3, 2004·Cancer Research·Belinda S ParkerStephen L Madden
May 4, 2005·Cancer Causes & Control : CCC·Edward Giovannucci
Nov 9, 2005·Molecular Cancer Therapeutics·Bret J StephensDaniel D Von Hoff
Feb 14, 2006·Biochemical and Biophysical Research Communications·Lirong PengChengchao Shou
May 2, 2006·Molecular Cancer Therapeutics·Sonoko Masuda, Glenville Jones
Jul 29, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L WangC Shou
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Feb 26, 2008·Breast Cancer Research and Treatment·Xuesong LuAndrea L Richardson
May 13, 2008·Molecular Cell·Shashwati BasakLaura D Attardi
Jul 3, 2008·Cancer Research·Marcus SchmidtMathias Gehrmann
Feb 28, 2009·Pathology Oncology Research : POR·Tingting RenChengchao Shou
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N BerradaF André
Nov 6, 2010·Journal of Cellular Biochemistry·Abdul Qader O Al-Aidaroos, Qi Zeng
Dec 24, 2010·Nature Reviews. Cancer·Sofi G JulienMichel L Tremblay
Feb 10, 2011·The Oncologist·Clifford A Hudis, Luca Gianni
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Bala Basak Oven UstaaliogluMahmut Gumus
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Jun 13, 2013·Biochimica Et Biophysica Acta·Caroline E Nunes-XavierRafael Pulido
Jul 9, 2014·Breast Cancer Research and Treatment·Cynthia Villarreal-GarzaRebecca Dent
Oct 10, 2015·Cell·Giovanni CirielloCharles M Perou

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
transfection
PCR

Software Mentioned

GraphPad Prism
IncuCyte
Oncomine
SAS

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.